Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01135563 · ClinicalTrials.gov registry record · Phase 1
Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours
A Phase 1 study of Solid Tumors and Central Nervous System Tumors, sponsored by The Hospital for Sick Children.
- Completed
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
- 5
- Study locations
NCT01135563 is a Phase 1 study of Solid Tumors and Central Nervous System Tumors that has completed, run by The Hospital for Sick Children. The registered enrollment target is 14 participants, below the 284-participant average among 125 other Solid Tumors trials with a reported enrollment target (95% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT01135563, a Phase 1 study of Solid Tumors and Central Nervous System Tumors, has completed, sponsored by The Hospital for Sick Children.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
- 5
- Study locations
Study Summary
This study is a Phase I study using vinblastine and sirolimus in patients with relapsed solid tumors including selected brain tumors and lymphoma. The investigators hypothesis is that the combination administration of weekly vinblastine and sirolimus is safe.
Conditions Studied
Interventions
- DRUG Vinblastine and Sirolimus
Study Locations (5)
California
- Rady Children's Hospital-San Diego - San Diego
Missouri
- SSM Cardinal Glennon Children's Medical Center - St Louis
Vermont
- Fletcher Allen Health Care - Burlington
Ontario
- The Hospital for Sick Children - Toronto
Quebec
- CHU Sainte-Justine - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01135563
The ClinicalTrials.gov registry entry for NCT01135563 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 284-participant average among 125 other Solid Tumors trials with a reported enrollment target (95% lower). The listed sponsor is The Hospital for Sick Children, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Solid Tumors appearing as the primary indexed condition, and to 1 intervention - of which Vinblastine and Sirolimus is the first listed.
NCT01135563 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Missouri, Vermont.
Frequently Asked Questions
What is clinical trial NCT01135563 about?
NCT01135563 is a clinical study titled "Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours". This study is a Phase I study using vinblastine and sirolimus in patients with relapsed solid tumors including selected brain tumors and lymphoma. The investigators hypothesis is that the combination administration of weekly vinblastine and sirolimus is safe.
What is the current status of trial NCT01135563?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2010-04. Estimated completion is 2012-04.
What conditions does trial NCT01135563 study?
This clinical trial studies the following conditions: Solid Tumors, Central Nervous System Tumors.
What interventions are being tested in trial NCT01135563?
The interventions under investigation include: Vinblastine and Sirolimus (DRUG).
Who is sponsoring clinical trial NCT01135563?
This trial is sponsored by The Hospital for Sick Children, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01135563 being conducted?
This trial has 5 study locations across California, Missouri, Vermont, Ontario, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of INCB123667 in Subjects With Advanced Solid Tumors
RECRUITING · Phase 1
-
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
RECRUITING · Phase 1
-
Study of AUBE00 in Patients With Solid Tumors
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.